EXPERIMENTAL DESIGN: Using
DNA microarray analysis, we examined
VEGF and related gene expression in 71 newly diagnosed
malignant gliomas and analyzed the relationship to
edema and survival.
RESULTS AND CONCLUSIONS:
VEGF expression was predictive of survival in
tumors with little or no
edema [Cox proportional hazard model, 6.88; 95% confidence interval (95% CI), 2.61-18.1; P<0.0001], but not in
tumors with extensive
edema. The expression of several proangiogenic genes, including
adrenomedullin (correlation coefficient, 0.80),
hypoxia-inducible factor-1A (0.51), and
angiopoietin-2 (0.44), was correlated with
VEGF expression (all with P<0.0001), whereas that of several antiangiogenic genes was inversely correlated. The expression of six genes was increased greater than 3-fold in edematous versus nonedematous
tumors in the absence of increased
VEGF expression. The most increased,
neuronal pentraxin 2 (NPTX2, 7-fold change), was predictive of survival in
tumors with the highest levels of
edema, in contrast to
VEGF (hazard ratio, 2.73; 95% CI, 1.49-5.02; P=0.049). NPTX2 was tightly correlated with expression of the
water channel aquaporin-3 (0.74, P<0.0001). These results suggest that there are both
VEGF-dependent and
VEGF-independent pathways of
edema production in
gliomas and may explain why
edema is not reduced in some patients following anti-
VEGF treatment.